Literature DB >> 21714605

Home blood pressure for the management of hypertension: will it become the new standard of practice?

Lawrence R Krakoff1.   

Abstract

Accurate identification of hypertension is crucial for the prevention of cardiovascular disease. Home blood pressure monitoring (HBPM) provides superior prediction of cardiovascular disease, compared with clinic pressures. HBPM can be a valuable resource for the effective treatment of hypertension, when combined with other modalities used to improve patient education, lifestyle enhancement, adherence to medication and reduction of unnecessary clinic visits. In some developed nations, more than half of households with a hypertensive patient have a device for HBPM. The use of HBPM by patients and the acceptance of HBPM measurements by providers is increasing. The long-term effectiveness of HBPM, combined with telemetry for disease prevention, is promising. More research is still needed to establish its full value. It is predicted that HBPM has definite potential for more effective strategies to control hypertension and reduce the need for on-site clinical care.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714605     DOI: 10.1586/erc.11.64

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

Review 1.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

2.  Scaling up the use of home blood pressure monitoring in the management of hypertension in low-income countries: A step towards curbing the burden of hypertension.

Authors:  Valirie Ndip Agbor; Mazou N Temgoua; Jean Jacques N Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-31       Impact factor: 3.738

3.  Estimate of nocturnal blood pressure and detection of non-dippers based on clinical or ambulatory monitoring in the inpatient setting.

Authors:  Tan Xu; Yongqing Zhang; Xuerui Tan
Journal:  BMC Cardiovasc Disord       Date:  2013-05-21       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.